Ecstasy produces left ventricular dysfunction and oxidative stress in rats
Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductanc...
Gespeichert in:
Veröffentlicht in: | Cardiovascular research 2008-09, Vol.79 (4), p.662-670 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 670 |
---|---|
container_issue | 4 |
container_start_page | 662 |
container_title | Cardiovascular research |
container_volume | 79 |
creator | Shenouda, Sylvia K. Lord, Kevin C. McIlwain, Elizabeth Lucchesi, Pamela A. Varner, Kurt J. |
description | Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction. |
doi_str_mv | 10.1093/cvr/cvn129 |
format | Article |
fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2732062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvn129</oup_id><sourcerecordid>10.1093/cvr/cvn129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVoqZ20l_yAoksvgU30uVpdAolx4gRDDmmh-CLGWm2rdrNrJK2x_31kbJzm0sMwM8wz7wwvQueUXFKi-ZVdhxwdZfoEjamSsuBMyA9oTAipipKXfIROY_yTWymV-IRGtBJaloqM0ePUxgRxi1ehrwfrIm5dk_DadSl4O7QQcL2NzdDZ5PsOQ1fjfuNrSH7tcEzBxYh9hwOk-Bl9bKCN7sshn6Efd9Pvk1kxf7p_mNzMCyuUSAWvbVVTsFKDsMppaZfQEHAKiCKNKnVNLJSN1pJRzpSg1JW5ybXklWTAz9D1Xnc1LF9cbXevQmtWwb9A2JoevHk_6fxv86tfG6Y4IyXLAhd7ARv6GINrjruUmJ2jJjtq9o5m-Ou_197Qg4UZ-HYAIFpomwCd9fHIMSK1IKV64_ph9f-DxZ7zMbnNkYTw12QVJc3s58LMRbWYPE-4ueWvWtudhw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Shenouda, Sylvia K. ; Lord, Kevin C. ; McIlwain, Elizabeth ; Lucchesi, Pamela A. ; Varner, Kurt J.</creator><creatorcontrib>Shenouda, Sylvia K. ; Lord, Kevin C. ; McIlwain, Elizabeth ; Lucchesi, Pamela A. ; Varner, Kurt J.</creatorcontrib><description>Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvn129</identifier><identifier>PMID: 18495670</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Animals ; Biological and medical sciences ; Calcium Signaling - drug effects ; Cardiac myocytes ; Cardiology. Vascular system ; Cells, Cultured ; Diastole ; Dilatation, Pathologic ; Ecstasy ; Electric Stimulation ; Hallucinogens - administration & dosage ; Hallucinogens - toxicity ; Heart ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; Injections, Intravenous ; Kinetics ; Male ; MDMA ; Medical sciences ; Muscle Proteins - metabolism ; Myocardial Contraction - drug effects ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage ; N-Methyl-3,4-methylenedioxyamphetamine - toxicity ; Original ; Oxidative Stress - drug effects ; Pressure–volume loops ; Proteomics ; Rats ; Rats, Sprague-Dawley ; Systole ; Tyrosine - analogs & derivatives ; Tyrosine - metabolism ; Tyrosine nitration ; Ultrasonography ; Ventricular Dysfunction, Left - chemically induced ; Ventricular Dysfunction, Left - diagnostic imaging ; Ventricular Dysfunction, Left - metabolism ; Ventricular Dysfunction, Left - physiopathology</subject><ispartof>Cardiovascular research, 2008-09, Vol.79 (4), p.662-670</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org 2008</rights><rights>2008 INIST-CNRS</rights><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</citedby><cites>FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20594067$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18495670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shenouda, Sylvia K.</creatorcontrib><creatorcontrib>Lord, Kevin C.</creatorcontrib><creatorcontrib>McIlwain, Elizabeth</creatorcontrib><creatorcontrib>Lucchesi, Pamela A.</creatorcontrib><creatorcontrib>Varner, Kurt J.</creatorcontrib><title>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Calcium Signaling - drug effects</subject><subject>Cardiac myocytes</subject><subject>Cardiology. Vascular system</subject><subject>Cells, Cultured</subject><subject>Diastole</subject><subject>Dilatation, Pathologic</subject><subject>Ecstasy</subject><subject>Electric Stimulation</subject><subject>Hallucinogens - administration & dosage</subject><subject>Hallucinogens - toxicity</subject><subject>Heart</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>Injections, Intravenous</subject><subject>Kinetics</subject><subject>Male</subject><subject>MDMA</subject><subject>Medical sciences</subject><subject>Muscle Proteins - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage</subject><subject>N-Methyl-3,4-methylenedioxyamphetamine - toxicity</subject><subject>Original</subject><subject>Oxidative Stress - drug effects</subject><subject>Pressure–volume loops</subject><subject>Proteomics</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Systole</subject><subject>Tyrosine - analogs & derivatives</subject><subject>Tyrosine - metabolism</subject><subject>Tyrosine nitration</subject><subject>Ultrasonography</subject><subject>Ventricular Dysfunction, Left - chemically induced</subject><subject>Ventricular Dysfunction, Left - diagnostic imaging</subject><subject>Ventricular Dysfunction, Left - metabolism</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rGzEQhkVoqZ20l_yAoksvgU30uVpdAolx4gRDDmmh-CLGWm2rdrNrJK2x_31kbJzm0sMwM8wz7wwvQueUXFKi-ZVdhxwdZfoEjamSsuBMyA9oTAipipKXfIROY_yTWymV-IRGtBJaloqM0ePUxgRxi1ehrwfrIm5dk_DadSl4O7QQcL2NzdDZ5PsOQ1fjfuNrSH7tcEzBxYh9hwOk-Bl9bKCN7sshn6Efd9Pvk1kxf7p_mNzMCyuUSAWvbVVTsFKDsMppaZfQEHAKiCKNKnVNLJSN1pJRzpSg1JW5ybXklWTAz9D1Xnc1LF9cbXevQmtWwb9A2JoevHk_6fxv86tfG6Y4IyXLAhd7ARv6GINrjruUmJ2jJjtq9o5m-Ou_197Qg4UZ-HYAIFpomwCd9fHIMSK1IKV64_ph9f-DxZ7zMbnNkYTw12QVJc3s58LMRbWYPE-4ueWvWtudhw</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Shenouda, Sylvia K.</creator><creator>Lord, Kevin C.</creator><creator>McIlwain, Elizabeth</creator><creator>Lucchesi, Pamela A.</creator><creator>Varner, Kurt J.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20080901</creationdate><title>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</title><author>Shenouda, Sylvia K. ; Lord, Kevin C. ; McIlwain, Elizabeth ; Lucchesi, Pamela A. ; Varner, Kurt J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-3dc8d1ac59a4c7e95cbaf0ae7a070f769d0ca6f99521327411e699513253852a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Calcium Signaling - drug effects</topic><topic>Cardiac myocytes</topic><topic>Cardiology. Vascular system</topic><topic>Cells, Cultured</topic><topic>Diastole</topic><topic>Dilatation, Pathologic</topic><topic>Ecstasy</topic><topic>Electric Stimulation</topic><topic>Hallucinogens - administration & dosage</topic><topic>Hallucinogens - toxicity</topic><topic>Heart</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>Injections, Intravenous</topic><topic>Kinetics</topic><topic>Male</topic><topic>MDMA</topic><topic>Medical sciences</topic><topic>Muscle Proteins - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage</topic><topic>N-Methyl-3,4-methylenedioxyamphetamine - toxicity</topic><topic>Original</topic><topic>Oxidative Stress - drug effects</topic><topic>Pressure–volume loops</topic><topic>Proteomics</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Systole</topic><topic>Tyrosine - analogs & derivatives</topic><topic>Tyrosine - metabolism</topic><topic>Tyrosine nitration</topic><topic>Ultrasonography</topic><topic>Ventricular Dysfunction, Left - chemically induced</topic><topic>Ventricular Dysfunction, Left - diagnostic imaging</topic><topic>Ventricular Dysfunction, Left - metabolism</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shenouda, Sylvia K.</creatorcontrib><creatorcontrib>Lord, Kevin C.</creatorcontrib><creatorcontrib>McIlwain, Elizabeth</creatorcontrib><creatorcontrib>Lucchesi, Pamela A.</creatorcontrib><creatorcontrib>Varner, Kurt J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shenouda, Sylvia K.</au><au>Lord, Kevin C.</au><au>McIlwain, Elizabeth</au><au>Lucchesi, Pamela A.</au><au>Varner, Kurt J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ecstasy produces left ventricular dysfunction and oxidative stress in rats</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>79</volume><issue>4</issue><spage>662</spage><epage>670</epage><pages>662-670</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Aims Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. Methods and results Echocardiography and pressure–volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. Conclusion The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18495670</pmid><doi>10.1093/cvr/cvn129</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-6363 |
ispartof | Cardiovascular research, 2008-09, Vol.79 (4), p.662-670 |
issn | 0008-6363 1755-3245 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2732062 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Biological and medical sciences Calcium Signaling - drug effects Cardiac myocytes Cardiology. Vascular system Cells, Cultured Diastole Dilatation, Pathologic Ecstasy Electric Stimulation Hallucinogens - administration & dosage Hallucinogens - toxicity Heart Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Ventricles - drug effects Heart Ventricles - metabolism Injections, Intravenous Kinetics Male MDMA Medical sciences Muscle Proteins - metabolism Myocardial Contraction - drug effects Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism Myocytes, Cardiac - pathology N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage N-Methyl-3,4-methylenedioxyamphetamine - toxicity Original Oxidative Stress - drug effects Pressure–volume loops Proteomics Rats Rats, Sprague-Dawley Systole Tyrosine - analogs & derivatives Tyrosine - metabolism Tyrosine nitration Ultrasonography Ventricular Dysfunction, Left - chemically induced Ventricular Dysfunction, Left - diagnostic imaging Ventricular Dysfunction, Left - metabolism Ventricular Dysfunction, Left - physiopathology |
title | Ecstasy produces left ventricular dysfunction and oxidative stress in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ecstasy%20produces%20left%20ventricular%20dysfunction%20and%20oxidative%20stress%20in%20rats&rft.jtitle=Cardiovascular%20research&rft.au=Shenouda,%20Sylvia%20K.&rft.date=2008-09-01&rft.volume=79&rft.issue=4&rft.spage=662&rft.epage=670&rft.pages=662-670&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1093/cvr/cvn129&rft_dat=%3Coup_pubme%3E10.1093/cvr/cvn129%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18495670&rft_oup_id=10.1093/cvr/cvn129&rfr_iscdi=true |